US3740399A - Diamino-s-triazines - Google Patents
Diamino-s-triazines Download PDFInfo
- Publication number
- US3740399A US3740399A US00114383A US3740399DA US3740399A US 3740399 A US3740399 A US 3740399A US 00114383 A US00114383 A US 00114383A US 3740399D A US3740399D A US 3740399DA US 3740399 A US3740399 A US 3740399A
- Authority
- US
- United States
- Prior art keywords
- grams
- added
- solution
- percent
- triazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical class NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 abstract description 35
- -1 ANTISPASMODICS Substances 0.000 abstract description 25
- 150000003839 salts Chemical class 0.000 abstract description 13
- JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical class C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 abstract description 6
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical class NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 abstract description 5
- 150000001733 carboxylic acid esters Chemical class 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 239000002934 diuretic Substances 0.000 abstract description 3
- 229940124575 antispasmodic agent Drugs 0.000 abstract description 2
- 239000003443 antiviral agent Substances 0.000 abstract description 2
- 229940121357 antivirals Drugs 0.000 abstract description 2
- 239000003638 chemical reducing agent Substances 0.000 abstract description 2
- 229940030606 diuretics Drugs 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 210000000653 nervous system Anatomy 0.000 abstract description 2
- 229940125723 sedative agent Drugs 0.000 abstract description 2
- 239000000932 sedative agent Substances 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 126
- 239000000243 solution Substances 0.000 description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 68
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 61
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 48
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 31
- 229910052708 sodium Inorganic materials 0.000 description 31
- 239000011734 sodium Substances 0.000 description 31
- 238000001914 filtration Methods 0.000 description 30
- 239000013078 crystal Substances 0.000 description 26
- 238000002844 melting Methods 0.000 description 24
- 230000008018 melting Effects 0.000 description 24
- 150000001875 compounds Chemical class 0.000 description 20
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 239000012046 mixed solvent Substances 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 7
- XBLVHTDFJBKJLG-UHFFFAOYSA-N Ethyl nicotinate Chemical compound CCOC(=O)C1=CC=CN=C1 XBLVHTDFJBKJLG-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 6
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 5
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 5
- HTYFFCPFVMJTKM-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-(diaminomethylidene)guanidine Chemical compound NC(N)=NC(N)=NC1=CC=C(Cl)C=C1 HTYFFCPFVMJTKM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 4
- WDAXFOBOLVPGLV-UHFFFAOYSA-N ethyl isobutyrate Chemical compound CCOC(=O)C(C)C WDAXFOBOLVPGLV-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- JRMAQQQTXDJDNC-UHFFFAOYSA-M 2-ethoxy-2-oxoacetate Chemical compound CCOC(=O)C([O-])=O JRMAQQQTXDJDNC-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000005840 aryl radicals Chemical group 0.000 description 3
- 229960004111 buformin Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- UWULXAQFAQOSSY-UHFFFAOYSA-N ethyl 2-[4-(2-methylpropyl)phenyl]acetate Chemical compound CCOC(=O)CC1=CC=C(CC(C)C)C=C1 UWULXAQFAQOSSY-UHFFFAOYSA-N 0.000 description 3
- MCRPKBUFXAKDKI-UHFFFAOYSA-N ethyl pyridine-4-carboxylate Chemical compound CCOC(=O)C1=CC=NC=C1 MCRPKBUFXAKDKI-UHFFFAOYSA-N 0.000 description 3
- 229940064982 ethylnicotinate Drugs 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- SQZCAOHYQSOZCE-UHFFFAOYSA-N 1-(diaminomethylidene)-2-(2-methylphenyl)guanidine Chemical compound CC1=CC=CC=C1N=C(N)N=C(N)N SQZCAOHYQSOZCE-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IMYQQIJWTKUQRF-UHFFFAOYSA-N 2-N-(2,5-diethoxyphenyl)-6-propan-2-yl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(=NC(=N1)NC1=C(C=CC(=C1)OCC)OCC)C(C)C IMYQQIJWTKUQRF-UHFFFAOYSA-N 0.000 description 1
- JVVRKYFARAPTPB-UHFFFAOYSA-N 2-N-ethyl-6-[[4-(2-methylpropyl)phenyl]methyl]-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(=NC(=N1)NCC)CC1=CC=C(C=C1)CC(C)C JVVRKYFARAPTPB-UHFFFAOYSA-N 0.000 description 1
- ZVUWFSVBCDNSHP-UHFFFAOYSA-N 2-N-naphthalen-2-yl-6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(=NC(=N1)NC=1C=CC2=CC=CC=C2C1)C1=CC=CC=C1 ZVUWFSVBCDNSHP-UHFFFAOYSA-N 0.000 description 1
- IBWXAMPUVRBFIS-UHFFFAOYSA-N 2-benzyl-1-(diaminomethylidene)guanidine Chemical compound NC(N)=NC(N)=NCC1=CC=CC=C1 IBWXAMPUVRBFIS-UHFFFAOYSA-N 0.000 description 1
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 1
- OAOYLHDSLIUMRV-UHFFFAOYSA-N 2-pyridin-4-yl-1,3,5-triazine Chemical compound C1=NC=CC(C=2N=CN=CN=2)=C1 OAOYLHDSLIUMRV-UHFFFAOYSA-N 0.000 description 1
- VIUDTWATMPPKEL-UHFFFAOYSA-N 3-(trifluoromethyl)aniline Chemical compound NC1=CC=CC(C(F)(F)F)=C1 VIUDTWATMPPKEL-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WRFYIYOXJWKONR-UHFFFAOYSA-N 4-bromo-2-methoxyaniline Chemical compound COC1=CC(Br)=CC=C1N WRFYIYOXJWKONR-UHFFFAOYSA-N 0.000 description 1
- HAAZMOAXEMIBAJ-UHFFFAOYSA-N 4-chloro-2-methylquinazoline Chemical compound C1=CC=CC2=NC(C)=NC(Cl)=C21 HAAZMOAXEMIBAJ-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- ICXXXLGATNSZAV-UHFFFAOYSA-N butylazanium;chloride Chemical compound [Cl-].CCCC[NH3+] ICXXXLGATNSZAV-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- SJMLNDPIJZBEKY-UHFFFAOYSA-N ethyl 2,2,2-trichloroacetate Chemical compound CCOC(=O)C(Cl)(Cl)Cl SJMLNDPIJZBEKY-UHFFFAOYSA-N 0.000 description 1
- JFIRSSNNKZUDHZ-UHFFFAOYSA-N ethyl 4,4,4-trichlorobutanoate Chemical compound CCOC(=O)CCC(Cl)(Cl)Cl JFIRSSNNKZUDHZ-UHFFFAOYSA-N 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- NVJAXNOSRPVIIT-UHFFFAOYSA-N methyl 2-[4-(2-methylpropyl)phenyl]acetate Chemical compound COC(=O)CC1=CC=C(CC(C)C)C=C1 NVJAXNOSRPVIIT-UHFFFAOYSA-N 0.000 description 1
- YNZYUHPFNYBBFF-UHFFFAOYSA-N methyl 2-[4-(2-methylpropyl)phenyl]propanoate Chemical compound COC(=O)C(C)C1=CC=C(CC(C)C)C=C1 YNZYUHPFNYBBFF-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- ZQWPRMPSCMSAJU-UHFFFAOYSA-N methyl cyclohexanecarboxylate Chemical compound COC(=O)C1CCCCC1 ZQWPRMPSCMSAJU-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-M oxidooxomethyl Chemical compound [O-][C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-M 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- CUQCMXFWIMOWRP-UHFFFAOYSA-N phenyl biguanide Chemical compound NC(N)=NC(N)=NC1=CC=CC=C1 CUQCMXFWIMOWRP-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Definitions
- R is a member selected from the group consisting of a substituted or unsubstituted alkyl radical, aryl radical, cycloalkyl radical, or heterocyclic residue and R is a member selected from the group consisting of a hydrogen atom, a hydroxyl radical, carboxyl radical, substituted or unsubstituted alkyl radical, aryl radical, cycloalkyl radical or heterocyclic residue
- R is a member selected from the group consisting of a hydrogen atom, a hydroxyl radical, carboxyl radical, substituted or unsubstituted alkyl radical, aryl radical, cycloalkyl radical or heterocyclic residue
- R --COOR (III) (wherein R is hydrogen atom, alkoxycarbonyl radical, substituted or unsubstituted alkyl radical, aryl radical, cycloalkyl radical or heterocyclic residue and R is a lower alkyl radical) in the presence of a basic substance.
- the compounds according to the invention are useful as medicines possessing a broad range of bioactivities such as antiphlogistic, blood vessel expansson, sedative action on the central nervous system, antiviral, antispasmodic, blood sugar reductive, diuretic, and adrenal cortex hormone secretion efiect etc. for the benefit of birds and mammals including civilization.
- the salt of the substituted diguanide which is expressed by the general Formula II can be easily obtained by the reaction of a primary amino salt, for example its hydrochloride and dicyandiamide by heating without using a solvent or with suitable solvents such as water, alcohol, etc.
- the substituted diguanide salt which is produced by the above method need not be used in purified form but can be used as prepared for the following reactions. When the free compound is needed, it can be prepared by a conventional method.
- substituted diguanides of the general Formula II which are suitable for producing a triazine within the range of the general Formula I are as follows: Phenyldiguanide, p-tolyldiguanide, o-tolyldiguanide, mtolyldiguanide, 2,4 xylyldiguanide, p-ethylphenyldiguanide, p-chlorophenyldiguanide, p-fiuorophenyldiguanide, p-bromophenyldiguanide, p-iodophenyldiguanide, 2,5 dichlorophenyldiguanide, o-sulfhydrylphenyldiguanide, m-trifluoromethylphenyl-diguanide, 2,5 diethoxyphenyldiguanide, 2,5 dimethoxyphenyldiguanide, unaphthyldiguanide, fi-naph
- n-octadecyldtiguanide cyclohexyldiguanide, cyclopentyldiguanide, 5 isoquinolyldiguanide, 5 chloro 8 isoquinolyldiguanide, 2 methyl 1,2,3,4-tetrahydro-8-isoquinolyldiguanide, etc.
- Examples of suitable carboxylic acid esters represented by the general Formula III which can be reacted with substituted diguanides of the general Formula II or their salts for the production of a triazine within the range of the general Formula I are as follows: ethyl formate, ethyl acetate, ethyl propionate, n-ethyl butyrate, ethyl isobutyrate, ethyl benzoate, ethyl toluylate, ethyl chloroacetate, ethyl bromoacetate, methyl p-isobutylphenylacetate, methyl 2-(p-isobutylphenyl)-propionate, ethyl oxalate, ethyl trichloroethylacetate, ethyl nicotinate, ethyl isonicotinate, methyl cyclohexancarboxylate, ethyl cyclohe
- a sodium alcoholate in which the alcohol is a lower aliphatic alcohol is especially advantageous among the basic materials which may be used for the reaction between a substituted diguanide of the general Formula II or its salt and a carboxylic acid ester of the general Formula III.
- Any kind of solvent can be used for the above reaction, if it does not interfere therewith, but a lower aliphatic alcohol is especially preferred and mixtures of a lower aliphatic alcohol and various other organic solvents are also recommended.
- the reaction is usually run atroom temperature, but it can be done by cooling or heating, if necessary. A reaction time of several hours to some seventy hours is necessary for the completion of the reaction and an expected compound can be obtained in a high yield by the process of this invention.
- Triazines of the general Formula I produced according to the process of this invention can be used in a form of free base or its salt which is produced by reacting the free base and various acids.
- the acids used for this purpose are hydrochloric acid, hydro-bromic acid, sulfuric acid, nitric acid, phosphoric acid, perchloric acid, formic acid, acetic acid, propionic acid, oxalic acid, succinic acid, glycolic acid, nicotinic acid, tartaric acid, maleic acid, malic acid, lactic acid, pamoic acid, citric acid, ascorbic acid, methansulfonic acid, salicylic acid, benzoic acid, cyclohexanesulfamic acid or other similar acids which are adaptable to the manufacture of medicines.
- a solution containing 1.5 grams of metallic sodium dissolved 25 ml. of methanol is poured into a solution containing 13.2 grams of B-naphthyldiguanide hydrochloride dissolved in 50 ml. of methanol at room temperature. Further 11.0 grams of ethyl p-isobutylphenylacetate are added to this solution and the mixture is left as it is at room temperature for 72 hours after sufiicient stirring. Water is added until a precipitate is not deposited from the reaction solution and it is further left as it is for 24 hours.
- the filtered crystals are recrystallized from a mixed solvent of ethanol and water and 8.2 grams of 2 amino 4-cyclohexylamino-6-(p-tolyl)-1,3,5- triazine havingmelting point of 152.5-153.5 C. are obtained.
- Ethanol containing 1 equivalent of phosphoric acid is added to an ethanol solution of the above 2-amino-4-(pphenylanilino) 6 (p-isobutyl-a-methylbenzyl)-1,3,5-triazine, and the monophosphate is obtained.
- the monophosphate is obtained.
- the monobenzoic acid addition salt is obtained.
- C CI1NH bi N f E R2 wherein R represents phenyl substituted by fluoro, chloro, iodo, mercapto, trifluoromethyl, phenyl, ethoxy, nitro or methyl and R represents pyridyl, an alkyl group of 1 to 3 carbon atoms, phenyl, p-isobutylbenzyl or P-lSObUtyl-(X- methylbenzyl; or a pharmaceutically acceptable acid-addition salt thereof.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
THERE ARE DISCLOSED NOVEL S-TRIAZINE DERIVATIVES AND SALTS THEREOF, THEY CAN BE USED AS THERAPEUTICES HAVING ACTIVITY AS ANTIPHLOGISTICS, BLOOD VESSEL EXPANDERS, NERVOUS SYSTEM SEDATIVES, ANTIVIRALS, ANTISPASMODICS, BLOOD SUGAR REDUCERS AND DIURETICS. THEY ARE PREPARED BY THE REACTION OF A SUBSTITUTED DIGUANIDE OR SALT THEREOF WITH A CARBOXYLIC ACID ESTER.
Description
United States Patent 3,740,399 DIAMINO-s-TRIAZINES Satoshi Murai, Yokaichi, Koichi Yoshida, Takatsuki, and
Chikanori Tomioka, Kyoto, Japan, assignors to Kakenyalru Kako Kabushiki Kaisha, Tokyo-to, Japan No Drawing. Filed Feb. 10, 1971, Ser. No. 114,383 Claims priority, application Japan, May 13, 1970, 45/ 40,664 Int. Cl. C07d 55/20 US. Cl. 260-249.8 14 Claims ABSTRACT OF THE DISCLOSURE There are disclosed novel S-triazine derivatives and salts thereof. They can be used as therapeutices having activity as antiphlogistics, blood vessel expanders, nervous system sedatives, antivirals, antispasmodics, blood sugar reducers and diuretics. They are prepared by the reaction of a substituted diguanide or salt thereof with a carboxylic acid ester.
DETAILED EXPLANATION OF THE INVENTION This invention relates to novel S-triazine derivatives which are expressed by the following general formula:
(wherein R is a member selected from the group consisting of a substituted or unsubstituted alkyl radical, aryl radical, cycloalkyl radical, or heterocyclic residue and R is a member selected from the group consisting of a hydrogen atom, a hydroxyl radical, carboxyl radical, substituted or unsubstituted alkyl radical, aryl radical, cycloalkyl radical or heterocyclic residue) and their salts, and also relates to a process for producing S-triazine derivatives and their salts by reacting a substituted diguanidine of general formula:
(wherein R is the same as above mentioned) or its salt and a carboxylic acid ester of the following general formula:
R --COOR (III) (wherein R is hydrogen atom, alkoxycarbonyl radical, substituted or unsubstituted alkyl radical, aryl radical, cycloalkyl radical or heterocyclic residue and R is a lower alkyl radical) in the presence of a basic substance.
The compounds according to the invention are useful as medicines possessing a broad range of bioactivities such as antiphlogistic, blood vessel expansson, sedative action on the central nervous system, antiviral, antispasmodic, blood sugar reductive, diuretic, and adrenal cortex hormone secretion efiect etc. for the benefit of birds and mammals including mankind.
The compounds shown in the general Formulae II and III, which are used for the preparation of the compounds of general Formula I can be obtained at a cheap price and in a large quantity and the yields on their reaction are so excellent that the compounds according to the invention are commercially attractive.
The salt of the substituted diguanide which is expressed by the general Formula II can be easily obtained by the reaction of a primary amino salt, for example its hydrochloride and dicyandiamide by heating without using a solvent or with suitable solvents such as water, alcohol, etc. The substituted diguanide salt which is produced by the above method need not be used in purified form but can be used as prepared for the following reactions. When the free compound is needed, it can be prepared by a conventional method.
Examples of substituted diguanides of the general Formula II which are suitable for producing a triazine within the range of the general Formula I are as follows: Phenyldiguanide, p-tolyldiguanide, o-tolyldiguanide, mtolyldiguanide, 2,4 xylyldiguanide, p-ethylphenyldiguanide, p-chlorophenyldiguanide, p-fiuorophenyldiguanide, p-bromophenyldiguanide, p-iodophenyldiguanide, 2,5 dichlorophenyldiguanide, o-sulfhydrylphenyldiguanide, m-trifluoromethylphenyl-diguanide, 2,5 diethoxyphenyldiguanide, 2,5 dimethoxyphenyldiguanide, unaphthyldiguanide, fi-naphthyldiguanide, p-nitrophenyldiguanide, benzyldiguanide, phenethyldiguanide, p-isopropylbenzyldiguanide, methyldiguanide, ethyldiguanide,
' n-butyldiguanide, n-hexyldiguanide, n-dodecyldiguanide,
n-octadecyldtiguanide, cyclohexyldiguanide, cyclopentyldiguanide, 5 isoquinolyldiguanide, 5 chloro 8 isoquinolyldiguanide, 2 methyl 1,2,3,4-tetrahydro-8-isoquinolyldiguanide, etc.
Examples of suitable carboxylic acid esters represented by the general Formula III which can be reacted with substituted diguanides of the general Formula II or their salts for the production of a triazine within the range of the general Formula I are as follows: ethyl formate, ethyl acetate, ethyl propionate, n-ethyl butyrate, ethyl isobutyrate, ethyl benzoate, ethyl toluylate, ethyl chloroacetate, ethyl bromoacetate, methyl p-isobutylphenylacetate, methyl 2-(p-isobutylphenyl)-propionate, ethyl oxalate, ethyl trichloroethylacetate, ethyl nicotinate, ethyl isonicotinate, methyl cyclohexancarboxylate, ethyl cyclohexylacetate and other alkyl esters.
A sodium alcoholate in which the alcohol is a lower aliphatic alcohol is especially advantageous among the basic materials which may be used for the reaction between a substituted diguanide of the general Formula II or its salt and a carboxylic acid ester of the general Formula III. Any kind of solvent can be used for the above reaction, if it does not interfere therewith, but a lower aliphatic alcohol is especially preferred and mixtures of a lower aliphatic alcohol and various other organic solvents are also recommended. The reaction is usually run atroom temperature, but it can be done by cooling or heating, if necessary. A reaction time of several hours to some seventy hours is necessary for the completion of the reaction and an expected compound can be obtained in a high yield by the process of this invention.
Triazines of the general Formula I produced according to the process of this invention can be used in a form of free base or its salt which is produced by reacting the free base and various acids. The acids used for this purpose, for example, are hydrochloric acid, hydro-bromic acid, sulfuric acid, nitric acid, phosphoric acid, perchloric acid, formic acid, acetic acid, propionic acid, oxalic acid, succinic acid, glycolic acid, nicotinic acid, tartaric acid, maleic acid, malic acid, lactic acid, pamoic acid, citric acid, ascorbic acid, methansulfonic acid, salicylic acid, benzoic acid, cyclohexanesulfamic acid or other similar acids which are adaptable to the manufacture of medicines.
This invention is illustrated by the following examples, it being clearly understood that the scope of this invention shall not be limited thereby.
(1) 179.7 grams of a-naphthylamine hydrochloride and 84 grams of dicyandiamide are dissolved in 400 ml. of water and the solution is refluxed for 1 hour. Precipitated ot-naphthyldiguanide hydrochloride after cooling is collected by filtration and washed with water and dried. 13.2 grams of a-naphthyldiguanide hydrochloride are added to a solution' containing 1.2 grams of metallic sodium dissolved in 70 ml. of methanol and the mixture is sufficiently stirred. Further 3.7 grams of ethyl formate are added to the solution, which is left as it is at room temperature for 48 hours. The reaction solution is allowed to cool after the addition of water. The resulting crystalline precipitate is collected by filtration and recrystallized With a mixed solvent of ethanol and water. Thus 8.5 grams of 2-amino-4-(oc-naphthylamino)-1,3,5- triazine with melting point of 248-249 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 65.81; H, 4.67; N, 29.52. Experimental value (percent): C, 65.90; H, 4.66; N, 29.31.
When the above-mentioned 2-amino 4 (or-naphthylamino)-1,3,5-triazine is recrystallized from a solution of hydrochloric acid, the monohydrochloride is obtained.
Elementary analysis of C H N Cl.Theoretical value (percent): C, 57.04; H. 4.42; N, 25.59; Cl, 12.95. Experimental value (percent): C, 57.31; H, 4.35; N, 25.57; Cl, 12.78.
(2) 13.2 grams of a-naphthyldiguanide hydrochloride are added to a solution containing 1.2 grams of metallic sodium dissolved in 70 ml. of methanol and the mixture is sufiiciently stirred. Further 4.4 grams of ethyl acetate are added to the solution, which is left as it is at room temperature for 48 hours. The reaction solution is allowed to cool after the addition of Water. The resulting crystalline precipitate is collected by filtration and recrystallized from a mixed solvent of ethanol and water. Thus 8.8 grams of Z-amino 4 (or-naphthylamino)--6-methyl- 1,3,5-triazine with melting point of 185-186 C. are obtained.
Elementary analysis of C I I N .Theoretical value (percent): C, 66.92; H, 5.21; N, 27.87. Experimental value (percent): C, 66.90; H, 4.98; N, 27.99.
When the above mentioned Z-amino 4 (oz-naphthylamino)-6-methyl-1,3,5-triazine is recrystallized from a solution of hydrochloric acid, the monohydrochloride is obtained.
Elementary analysis of C H N Cl.Theoretical value (percent): C, 58.44; H, 4.90; N, 24.34; Cl, 12.32. Experimental value (percent): C, 58.61; H, 4.77; N, 24.30; Cl, 12.20.
(3) A solution containing 1.5 grams of metallic sodium dissolved in 25 ml. of methanol is poured into a solution containing 13.2 grams of a-naphthyldiguanide hydrochloride dissolved in 50 ml. of methanol at room temperature. Further 5.1 grams of ethyl porpionate are added to the solution, which is left as it is at room temperature for 72 hours after sufiicient stirring. The reaction solution is allowed to cool after the addition of Water. The resulting crystalline precipitate is collected by filtration and recrystallized from n-butanol. Thus 9.7 grams of 2-amino-4- (a-naphthylamino -6-ethyl-1,3,5-triazine with melting point of 209210 C. is obtained.
Elementary analysis of C H 'N .Theoretical value (percent): C, 67.90; H, 5.70; N, 26.40. Experimental value (percent): C, 68.14; H, 5.77; N, 26.29.
(4) A solution containing 2.5 grams of metallic sodium dissolved into 25 ml. of methanol is poured into a solution containing 13.2 grams of B-naphthyldiguanide hydrochloride dissolved in 50 ml. of methanol at room temperature. Further 6.8 grams of methylbenzoate added to this solution and the mixture is refluxed for 5 hours. After it is left as it is for 24 hours, water is added until a precipitate is not deposited from the reaction solution and it is further left as it is for 24 hours. The resulting precipitate is collected by filtration, and recrystallized from n-butanol to obtain 9.5 grams of 2-amino-4-( 3- naphthylamino) 6 phenyl 1,3,5 triazine with melting point of 164-165 C.
Elementary analysis of C H N .Theoretical value (percent): C, 72.83; H, 4.83; N, 22.35. Experimental value (percent): C, 72.59; H, 4.82; N, 22.37.
When ethanol containing 1 equivalent of hydrochloric acid is added to an ethanol solution containing the abovementioned 2 amino-4-(B-naphthylamino)-6-phenyl-1,3,5- triazine, the monohydrochloride is obtained. When 1 equivalent of acetylsalicylic acid is used in the same Way, the monoacetylsalicylic addition salt is obtained.
(5) A solution containing 1.5 grams of metallic sodium dissolved 25 ml. of methanol is poured into a solution containing 13.2 grams of B-naphthyldiguanide hydrochloride dissolved in 50 ml. of methanol at room temperature. Further 11.0 grams of ethyl p-isobutylphenylacetate are added to this solution and the mixture is left as it is at room temperature for 72 hours after sufiicient stirring. Water is added until a precipitate is not deposited from the reaction solution and it is further left as it is for 24 hours. By collecting the precipitate by [filtration and recrystallizing from a mixed solution of ethanol and Water, 14.5 grams of 2-amino-4-(B-naphthylamino)-6-(pisobutylbenzyl)-1,3,5-triazine with melting point of 178- 179C. are obtained.
Elementary analysis of C H N .--Theoretical value (percent): C, 75.17; H, 6.57; N, 18.26. Experimental value (percent): C, 75.18; H, 6.86; N, 18.10.
(6) 25.0 grams of m-aminobenzotrifluoride and 13 grams of dicyandiamide are dissolved into 62 ml. of 10% hydrochloric acid and the solution is refluxed for 1 hour. Precipitated m-trifluoromethylphenyldiguanide hydrochloride after cooling is collected by filtration and washed with water and dried.
14.1 grams of m-t-rifiuoromethylphenyldiguanide hydrochloride are added to a solution containing 1.2 grams of metallic sodium dissolved in 70 ml. of methanol and the mixture is sufliciently stirred. Further 11.0 grams of ethyl p-isobutylphenylacetate added to the solution, which is left as it is at room temperature for 72 hours. Twice the volume of Water is added to the reaction solution, which is allowed to cool. The resulting crystalline precipitate is collected by filtration and recrystallized with a mixed solvent of ethanol and water. Thus 11.6 grams of 2-amino 4 (m-trifluorornethylanilino)-6-(p-isobutylbenzyl)-1,3,5-triazine are obtained.
Elementary analysis of C H N F .Theoretical value (percent): C, 62.83; H, 5.52; N, 17.45. Experimental value (percent): C, 62.71; H, 5.50; N, 17.39.
(7) A solution containing 1.5 grams of metallic sodium dissolved into 22 ml. of methanol is poured into a solution containing 14.1 grams of m-trifluoromethylphenyldiguanide hydrochloride dissolved in 50 ml. of methanol. Further 7.6 grams of ethyl isonicotinate are added to this solution and the mixture is left as it is at room temperature for 72 hours. After addition of 200- ml. of water to the reaction solution, it is left as it is for 24 hours. The resulting crystalline precipitate is collected by filtration and recrystallized with a mixed solvent of ethanol and Water. Thus 10.9 grams of 2-amino-4-(m-trifluoromethylanilino)-6-(4-pyridyl)-1,3,5-triazine with melting point of 229230 C. are obtained.
Elementary analysis of C H N F .Theoretical value (percent): C, 54.22; H, 3.34; N, 25.29. Experimental value (percent): C, 54.32; H, 3.11; N, 25.29.
('8) 34 grams of dicyandiamide and 36 ml. of concentrated hydrochloric acid are added to a solution containing 58 grams of S-aminoisoquinoline dissolved in ml. of isopropanol and the mixture is refluxed for 1.5 hours. Precipitated 5-isoquinolyldiguanide hydrochloride after cooling is collected by filtration and dried after Washing with a small quantity of ethanol. 3.8 grams of 5-isoquinolyldiguanide dihydrochloride are added to a solution containing 0.58 gram of metallic sodium dissolved in 25 ml. of absolute methanol and further 0.95 gram of ethyl formate is added and the mixture is sufliciently stirred. After being left as it is at room temperature for 48 hours, the reaction solution is further left as it is with an addition of water for 24 hours.
The resulting crystalline precipitate is collected by filtration and recrystallized from a mixed solvent of ethanol and water. Thus, 1.7 grams of 2-amino-4-(5-isoquinolyl amino)-1,3,5-triazine with melting point of 259260 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 60.50; H, 4.23; N, 35.27. Experimental value (percent): C, 60.72; H, 4.20; N, 35.03.
(9) 4.2 grams of 5-chloro-8-isoquinolyldiguanide dihydrochloride are added to a solution containing 0.58 gram of metallic sodium dissolved in 25 ml. of absolute methanol and further 2.75 grams of ethyl p-isobutylphenylacetate are added. The mixture is sufficiently stirred. After being left as it is at room temperature for 48 hours, the reaction solution is further left as it is with an addition of water for 24 hours. The precipitated crystals are collected by filtration and recrystallized from a mixed solvent of ethanol and water. Thus, 4.1 grams of 2-amino-4-(5-chloro 8 isoquinolylamino) 6 (p-isobutylbenzyl)-1,3,5-triazine having melting point of 126- 127 C. obtained.
Elementary analysis of C H N Cl.Theoretical value (percent): C, 65.94; H, 5.53; N, 20.06; Cl, 8.46. Experimental value (percent): C, 65.84; H, 5.78; N, 20.07; Cl, 8.16.
(10) 10.7 grams of phenydiguanide hydrochloride added to a solution in which 1.2 grams of metallic sodium has been dissolved into 70 ml. of methanol, and further 8.2 grams of ethyl p-toluylate added, and the mixture is sufficiently stirred. After being left as it is at room temperature for 48 hours, the reaction solution is added with water and allowed to cool. The precipitated crystals are collected by filtration and recrystallized from n-butanol, thus obtaining 11.0 grams of 2-amino-4-anilino-6-(ptolyl)-1,3,5-triazine having melting point of 199-200" C.
Elementary analysis of C H N .Theoretical value (percent): C, 69.29; H, 5.45; N, 25.25. Experimental value (percent): C, 69.30; H, 5.55; N, 25.27.
(11) 11.4 grams of p-tolyldiguanide hydrochloride are added to a solution in which 1.5 grams of metallic sodium have been dissolved in 70 ml. of methanol, and further 7.6 grams of ethyl isonicotinate are added. The mixture is sufliciently stirred. After being left as it is at room temperature for 48 hours, the reaction solution is added with water and allowed to cool. The precipitated crystals are collected by filtration and recrystallized from n-butanol. Thus, 10.0 grams of 2-amino-4-(p-toluidino)-6-(4- pyridyl)-1,3,5-triazine having melting point of 236-237 C. are obtained.
Elementary analysis of C H N .-Theoretica1 value (percent): C, 64.73; H, 5.07; N, 30.20. Experimental value (percent): C, 65.00; H, 4.85; N, 30.17.
(12) 11.4 grams of o-tolyldiguanide hydrochloride are added to a solution in which 1.5 grams of metallic sodium have been dissolved in 70 ml. of methanol, and further 11.7 grams of ethyl 2-(p-isobutylphenyl) propionate are added, and thereafter stirred sufi'lciently. After being left as it is at room temperature for 72 hours, water is added to the reaction solution and allowed to cool. Then, the precipitated crystals are collected by filtration, and recrystallized from a mixed solvent of ethanol and water. Thus, 14.3 grams of 2 amino 4 (o-toluidino)-6- (p-isobutyl-u-methyl benzyl)-1,3,5-triazine having melting point of 132-134 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 73.10; H, 7.53; N, 19.37. Experimental value (percent): C, 73.03; H, 7.48; N, 19.57.
13) 11.4 grams of m-tolyldiguanide hydrochloride are added to a solution in which 1.5 grams of metallic sodium have been dissolved in 70 ml. of methanol, and futher 7.6 grams of ethyl nicotinate are added thereto, and stirred sufficiently. After being left as it is at room temperature for 48 hours, water is added to the reacting solution and allowed to cool. By collecting by filtration the crystals precipitated therein and recrystallizing from nbutanol, 10.9 grams of 2-amino-4-(m-toluidino)-6-(3- pyridy1)-1,2,3,5-triazine having melting point of 216218 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 64.73; H, 5.07; N, 30.20. Experimental value (percent): C, 64.70; H, 5.27; N, 30.15.
(14) 34.5 grams of cyclohexylamine hydrochloride and 21.5 grams of dicyandiamide are ground uniformly. The mixture is melted on an oil bath at ISO- C., and maintained at this temperature for about 30 minutes. After being cooled, it is dissolved in hot methanol and cooled, and cyclohexyldiguanide hydrochloride is precipitated.
11.0 grams of cyclohexyldiguanide hydrochloride are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 40 ml. of methanol, and further 5.2 grams of ethyl propionate are added thereto, and stirred sufficiently. After being left as it is at room temperature for 72 hours, twice the volume of water is added to the reaction solution to cause white colored crystals to precipitate. The precipitated crystals are collected by filtration, and thereafter recrystallized from mixed solvent of ethanol and water, and 8.4 grams of 2-amino-4-cyc1ohexylamino-G-ethyl-1,3,5-triazine having melting point of 147-149 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 59.97; H, 8.24; N, 31.79. Experimental value (percent): C, 60.28; H, 8.21; N, 31.81.
(15) A solution in which 1.5 grams of metallic sodium have been dissolved into 22 ml. of methanol, is added to a solution in which 11.0 grams of cyclohexyldiguanide hydrochloride have been dissolved in 40 ml. of methanol. Further, 8.2 grams of ethyl p-toluylate are added to this solution, and stirred sufficiently. After being left as it is at room temperature for 72 hours, twice the volume of water is added to the reaction solution to cause the precipitation of crystals. The filtered crystals are recrystallized from a mixed solvent of ethanol and water and 8.2 grams of 2 amino 4-cyclohexylamino-6-(p-tolyl)-1,3,5- triazine havingmelting point of 152.5-153.5 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 68.06; H, 7.14; N, 24.08. Experimental value (percent): C, 67.86; H, 6.89; N, 25.09.
(16) 80.5 grams of p-fluoroaniline and 61.2 grams of dicyandiamide are dissolved in 290 ml. of 10% hydrochloric acid solution and the solution refluxed for one hour. After cooling, the precipitated p-fiuorophenyldiguanide hydrochloride is collected by filtration and dried. 11.5 grams of p-fluorophenyldiguanide hydrochloride are added to a solution in which 1.5 grams of metallic sodium have been dissolved in 70 ml. of methanol, and further 5.2 grams of ethyl propionate are added and stirred sufficiently. After being left as it is at room temperature for 72 hours, twice the volume of water is added to the reaction solution, and allowed to cool. The precipitated crystals are collected by filtration, and upon recrystallization from n-butanol, 8.3 grams of 2-amino-4-(pfluoroanilino)-6-ethyl-1,3,5-triazine having melting point of 160-161 C. are obtained.
Elementary analysis of C H N F.Theoretical value (percent): C, 56.64; H, 5.19; N, 30.03. Experimental value (percent): C, 56.49; H, 4.96; H, 30.00.
(17) 17.0 grams of p-iodophenyldiguanide hydrochloride are added to a solution in which 1.5 grams of metallic sodium have been dissolved into 70 ml. of methanol, and 4.4 grams of ethyl acetate is further added, and sufliciently stirred. After being left as it is at room temperature for 48 hours, twice the volume of water is added to the reaction solution, and allowed to cool. By collecting by filtration the precipitated crystals and recrystallized from n-butanol, 8.5 grams of 2-amino-4-(p-iodoanilino)-6-methyl-l, 3,5-triazine having melting point of 219-220 C. are obtained.
Elementary analysis of C H N I.--'Iheoretical value (percent): C, 36.72; H, 3.08; N, 21.41. Experimental value (percent): C, 36.98; H, 3.40; N, 21.40.
(18) 12.4 grams of p-chlorophenyldiguanide hydrochloride are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 70 m1. of methanol, and cooled to a temperature of -5 C. 7.3 grams of ethyl oxalate are added to this solution, stirred sufliciently, and left as it is at room temperature for 24 hours. After 001- lecting the precipitated crystals by filtration, they are washed with acetonitrile, and 8.8 grams of 2-amino-4- (pchlorophenylamino) 6-carboxyl-1,3-triazine, which decomposes at 210 C. are obtained.
Elementary analysis of C H O N Cl.Theoretical value (percent): C, 45.21; H, 3.04; O, 12.04; N, 26.36. Experimental value (percent): C, 44.93; H, 3.21; O, 11.82; N, 26.58.
(19) 13.2 grams of fi-naphthyldiguanide hydrochloride are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 120 ml. of methanol, and cooled to 05 C. 7.3 grams of ethyl oxalate are added to this solution and left as it is at room temperature for 24 hours. The precipitated crystals are collected by filtration, and thereafter washed by acetonitrile. 9.9 grams of Z-amino '4 (p-naphthylamino)-6-carboxyl-1,3,5-triazine which decompose at 210213 C. are obtained.
Elementary analysis of C H C N .Theoretical value (percent): C, 59.78; H, 3.94; N, 24.90. Experimental value (percent): C, 60.07; H, 3.94; N, 24.75.
(20) 12.3 grams of o-mercaptophenyldiguanide hydrochloride are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 70 ml. of methanol, and further 3.7 grams of ethyl formate are added thereto, and the solution is stirred sufliciently. After the solution has been left as it is at room temperature for 48 hours, water is added to the reaction solution and cooled. The precipitated crystals are filtered, and recrystallized from a mixed solvent of ethanol and Water, and 7.2 grams of 2 amino-4-(o-mercaptoanilino)-l,3,5-triazine having melting point of 138140 C. are obtained.
(21) 23 grams of o-mercaptophenyldiguanide hydrochloride are added to a solution in which 2.3 grams of metallic sodium have been dissolved in 75 m1. of methanol, and further 14 grams of ethyl benzoate are added and stirred sufliicently.
After being left as it is at room temperature for 72 hours, water is added to the reaction solution, and left as it is for 24 hours. The precipitated crystals are collected by filtration, and recrystallized from a mixed solvent of ethanol and water, and 13.6 grams of 2-amino-4- (o-mercaptoanilino)-6-phenyl-l,3,5-triazine having melting point of 168-169 C. are obtained.
(22) A solution in which 1.5 grams of metallic sodium has been dissolved in 20 ml. of methanol, is added to a suspension of 12.4 grams of p-chlorophenyldiguanide hydrochloride in 50 ml. of methanol, and stirred sufficiently. Further, 7.6 grams of ethyl nicotinate are added, and left as it is at room temperature for 72 hours. Water is added to the reaction solution, and thereafter the precipitated crystals are filtered, and recrystallized from n-butanol to obtain 8.3 grams of 2 amino-4-(p-chloroanilino)-6-(3- pyridyl)-l,3,5-triazine having melting point of 223-24" C.
Elementary analysis of C H N Cl.Theoretical value (percent): C, 56.29; H, 3.71; N, 28.13. Experimental value (percent): C, 56.18; H, 3.66; N, 28.30.
(23) 30 m1. of ethylene glycol are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 50 ml. of methanol, and further 129 grams of p-nitrophenyldiguanide hydrochloride are added. After the solution has been Well mixed, 4.0 grams of ethyl formate is added and left as it is for 48 hours, and thereafter twice the volume of water is added to the reaction solution, and allowed to cool. The crystals produced therein are collected by filtration and washed with acetonitrile, and 7.9 grams of 2-amino-4-(p-nitroanilino)-1,3,5-triazine are obtained.
Elementary analysis of C H 0 H .-Theoretical value (percent): C, 46.55; H, 3.47; N, 36.19. Experimental value (percent): C, 46.86; H, 3.29; N, 36.40.
5.5 grams of the above 2-amino-4-(p-nitroanilino)-1,3, 5-triazine is suspended in 75 ml. of methanol, and refluxed with the dropwise addition of time a solution in which 20 grams of stannous chloride has been dissolved in 23 ml. of concentrated hydrochloric acid. As the reaction progresses, the solution becomes transparent. After the addition has been finished, reflux is continued for 1.5 hours, and the same quantity of concentrated hydrochloric acid is added to the solution, and cooled down to 05 C. The precipitated crystals are collected by filtration, and Washed with cold concentrated hydrochloric acid. Then, by washing with acetone and drying, 4.2 grams of 2- amino 4- (p-aminoanilino)-1,3,5-triazine dihydrochloride are obtained.
Elementary analysis of C H N C1 .Theoretical value (percent): C, 39.29; H, 4.40; N, 30.54. Experimental value (percent): C, 39.12; H, 4.39; N, 30.30.
(24) 30 m1. of ethylene glycol are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 50 ml. of methanol, and 12.9 grams of p-nitrophenyldiguanide hydrochloride are further added. 11.7 grams of ethyl 2-(p-isobutylphenyl) propionate are added to the above solution which has been sufiiciently mixed, and after the solution is left as it is at room temperature for 72 hours, twice the volume of Water is added said solution, and allowed to cool.
The resulting crystals are filtered and washed with acetonitrile, then 15.0 grams of 2-amino-4-(p-nitroanilino)- 6 (p-isobutyl-ot-methylbenzyl)-1,3,5-triazine which decomposes 286289 C. are obtained.
Elementary analysis of C H O N .Theoretical value (percent): C, 64.27; H, 6.16; N, 21.41. Experimental value (percent): C, 64.31; H, 6.41; N, 21.39.
To a refluxing suspension of 9.3 grams of the above mentioned 2 amino 4-(p-nitroanilino)-6-(p-isobutyl-mmethylbenzyl)-1,3,5-triazine in ml. of methanol, there is added dropwise a solution in which 20 grams of stannous chloride have been dissolved in 23 grams of concentrated hydrochloric acid. As the reaction progresses, the solution becomes transparent. After the addition, the solution is refluxed for 2 hours, an equal volume of concentrated hydrochloric acid is added, and the solution is cooled down to 0-5 C.
The precipitated crystals are collected by filtration and washed with cold concentrated hydrochloric acid and dried. Then 8.1 grams of 2-amino-4-(p-aminoanilino)-6- (p-isobutyl 0c methylbenzyl)-1,3,5-triazine dihydrochloride are obtained.
Elementary analysis of C H N Cl .-Theoretical value (percent): C, 57.93; H, 6.48; N, 19.30. Experimental value (percent): C, 57.75; H, 6.24; N, 19.26.
(25) 12.4 grams of p-chlorophenyldiguanide hydrochloride added to a solution in which 1.2 grams of metallic sodium have been dissolved in 70 ml. of methanol, and sufiiciently mixed. To this solution, 9.6 grams of ethyl trichloroacetate are added and refluxed in a moderate flow rate for 7 hours. After cooling, the precipitated crystals are filtered and washed with hot Water and ethanol. 9.7 grams of 2-amino-4-(p-chloroanilino)-6-hydroxy-1,3,5-triazine (melting point being more than 270 C.) are obtained.
Elementary analysis of C H OH Cl.-Theoretica1 value (percent): C, 45.49; H, 3.39; N, 29.47. Experimental value (percent): C, 45.24; H, 3.31; N, 29.33.
(26) 50 grams of n-butylamine hydrochloride and 38.4 grams of dicyandiamide are uniformly mixed. This mixture is melted on an oil bath at a temperature of l30i5 C., and maintained at this temperature for about 4 hours. After cooling, the mixture is dissolved in hot methanol and cooled, and n-butyl-diguanide hydrochloride is precipitated. 9.7 grams of n-butyl-diguanide hydrochloride are added-to a solution in which 1.5 grams of metallic sodium have been dissolved in 50 ml. of methanol, and further grams of ethyl p-isobutylphenyl acetate are added thereto and sufiiciently stirred. After being left as it is for 72 hours, twice the volume of water is added to the reaction solution. The precipitated crystals are collected by filtration and recrystallized from a mixed solvent of ethanol and water. 13.5 grams of 2-amino-4-n-butylamino- 6-p-(isobutylbenzyl)-1,3,5-triazine having melting point of 99.5101 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 68.97; H, 8.68; N, 22.34. Experimental value (percent): C, 69.17; H, 8.79; N, 22.32.
(27) 6.4 grams of ethyldiguanide are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 50 ml. of methanol, and 11.0 grams of ethyl pisobutylphenylacetate are further added and sutficiently stirred. After being left as it is at room temperature for 72 hours, twice the volume of water is added to the reaction solution and left as it is for 24 hours. The precipitated crystals are collected by filtration and recrystallized from a mixture of ethanol and water, and 10.2 grams of 2-amino-4-ethylamino 6 (p-isobutylbenzyl)-1.3,5-triazine having melting point of 108111 C. are obtained.
Elementary analysis of C H N .Theoretical value (percent): C, 67.34; H, 8.12; N, 24.54. Experimental value (percent): C, 67.18; H, 8.18; N, 24.22.
(28) A solution in which 1.2 grams of metallic sodium have been dissolved in 20 ml. of methanol is added to a solution in which 12.6 grams of p-diphenyldiguanide have been dissolved in 50 ml. of methanol. 11.7 grams of ethyl 2-(p-isobutylphenyl) propionate are added and sufliciently stirred, and thereafter left as it is for 72 hours. After 200 ml. of water have been added to the reaction solution and allowed to cool, the precipitated crystals are collected by filtration and recrystallized from a mixed solvent of ethanol and water, and 17.8 grams of 2-amino-4-(p-diphenylamino)-6-(p-isobutyl-u-methylbenzyl)-1,3,5 triazine having melting point of 138139 C. are obtained.
Elementary analysis of C I-I N .Theoretical value (percent): C, 76.56; H, 6.90; N, 16.53. Experimental value (percent): C, 76.57; H, 7.13; N, 16.77.
Ethanol containing 1 equivalent of phosphoric acid is added to an ethanol solution of the above 2-amino-4-(pphenylanilino) 6 (p-isobutyl-a-methylbenzyl)-1,3,5-triazine, and the monophosphate is obtained. By the use of 1 equivalent of benzoic acid in similar manner, the monobenzoic acid addition salt is obtained.
(29) A solution in which 1.2 grams of metallic sodium have been dissolved in 20 m1. of methanol, is added to a solution in which 11.8 grams of 2-nitro-4-methyl-phenyldiguanide have been dissolved in 50 ml. of methanol. 11.7 grams of ethyl 2-(p-isobuty-lphenyl) propionate are further added and mixed sufficiently. Thereafter it is left as it is for 72 hours. After 200 ml. of Water has been added to the reaction solution and allowed to cool, the precipitated crystals are collected and recrystallized from n-butanol. 16.4 grams of 2-amino-4-(2-nitro-4-methyl-anilino)-6-(pisobutyl-a-methylbenzyl) 1,3,5 triazine having melting point of 203-205 C. are obtained.
Elementary analysis of C H O N .-Theoretical value (percent): C, 65.01; H, 6.45; N, 20.68. Experimental value (percent): C, 65.00; H, 6.28; N, 20.72.
(30) 15.0 grams of 2,5-diethoxyphenyldiguanide hydrochloride are added to a solution in which 1.2 grams of metallic sodium have been dissolved in 70 ml. of methanol, and 5.8 grams of ethyl isobutyrate are further added, and mixed sufiiciently. After being left as it is at room temperature for 48 hours, water is added and left as it is for 24 hours. The precipitated crystals are collected by filtration and recrystallized from a mixed solvent of ethanol and water and 11.8 grams of 2-amino-4-(2,5-diethoxy-anilino)-6-isopropyl-1,3,5-triazine having melting point of 162-163 C. are obtained.
Elementary analysis of C H O N .The0retical value (percent): C, 60.55; H, 7.30; N, 22.07. Experimental value (percent): C, 60.34; H, 7.38; N, 21.85.
What is claimed is:
1. A compound of the formula N R NH|C CI1NH bi N f E R2 wherein R represents phenyl substituted by fluoro, chloro, iodo, mercapto, trifluoromethyl, phenyl, ethoxy, nitro or methyl and R represents pyridyl, an alkyl group of 1 to 3 carbon atoms, phenyl, p-isobutylbenzyl or P-lSObUtyl-(X- methylbenzyl; or a pharmaceutically acceptable acid-addition salt thereof.
2. The compound of claim 1 which is 2-amino-4-(mtriiluoromethylanilino -6-(p'-isobutylbenzyl-1,3,5-triazine.
3. The compound of claim 1 which is 2-amino-4-(m-trifiuoromethylanilino)-6-(4-pyridyl)-1,3,5-triazine.
4. The compound of claim 1 which is 2-amino-4-(pfluoroanilino) -6-ethyl- 1,3 ,5 -triazine.
5. The compound of claim 1 which is 2-amino-4-(piodoanilino)-6-methyl-l,3,5-triazine.
6. The compound of claim 1 which is 2-amin0-4-(omercaptoanilino)-6-phenyl-1,3,5-triazine.
7. The compound of claim 1 which is 2-amino-4-(pchloroanilino -6- 3-pyridyl)-1,3,5-triazine.
8. The compound of claim 1 which is 2-amino-4-(pdiphenylamino) 6 (p-isobutyl-a-methylbenzyl)-1,3,5- triazine.
9. The compound of claim 1 which is 2-amino-4-(2,5- diethoxyanilino)-6-isopr0pyl-l,3,5-triazine.
10. The compound of claim 1 which is 2-arnino-4-(ptoluidino -6- (4-pyridyl 1 ,3,5-triazine.
11. The compound of claim 1 which is 2-amino-4-(0- toluidino) -6- (p-isobu tyl-u-methylbenzyl -1,3,5-triazine.
12. The compound of claim 1 which is 2-amino-4-(mtoluidino) -6- (3-pyridyl) -1,3,5-triazine.
13. The compound of claim 1 which is 2-arnino-4-(pnitroanilino) -6- (p-isobutyl-a-methylbenzyl 1,3,5-triazine.
14. The compound of claim 1 which is 2-amino-4-(2- nitro 4 methylanilino)-6-(p-isobutyl-ot-methylbenzyl)- 1,3,5-triazine.
References Cited UNITED STATES PATENTS 2,344,784 3/1944 Oldham 260249.9 2,630,433 3/1953 Kaiser et al. 260249.9 2,928,768 3/1960 Freedman et al. 260249.9 X 3,169,904 2/ 1965 Calderbank et al. 260249.9 X 3,471,491 10/ 1969 Narayanan 260249.9
OTHER REFERENCES Smolin et al.: s-Triazines and Derivatives, Interscience Pub., Inc., New York (1959), pp. 238-9.
JOHN M. FORD, Primary Examiner U.S. Cl. X.R.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP45040664A JPS4927592B1 (en) | 1970-05-13 | 1970-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3740399A true US3740399A (en) | 1973-06-19 |
Family
ID=12586784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00114383A Expired - Lifetime US3740399A (en) | 1970-05-13 | 1971-02-10 | Diamino-s-triazines |
Country Status (9)
Country | Link |
---|---|
US (1) | US3740399A (en) |
JP (1) | JPS4927592B1 (en) |
BE (1) | BE763425A (en) |
CH (1) | CH568304A5 (en) |
DE (1) | DE2121694B2 (en) |
FR (1) | FR2088532A1 (en) |
GB (1) | GB1353545A (en) |
NL (1) | NL148797B (en) |
SE (1) | SE394434B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0864567A1 (en) * | 1995-11-27 | 1998-09-16 | Idemitsu Kosan Company Limited | Triazine derivatives |
US6150362A (en) * | 1997-12-12 | 2000-11-21 | Henkin; Jack | Triazine angiogenesis inhibitors |
US6380194B1 (en) | 1996-10-01 | 2002-04-30 | Janssen Pharmaceutica N.V. | Substituted diamino-1,3,5-triazine derivatives |
WO2015007711A1 (en) * | 2013-07-16 | 2015-01-22 | Basf Se | Herbicidal azines |
US10029992B2 (en) | 2014-04-23 | 2018-07-24 | Basf Se | Diaminotriazine compounds and their use as herbicides |
US10941122B2 (en) | 2014-04-11 | 2021-03-09 | Basf Se | Diaminotriazine derivatives as herbicides |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20011532A3 (en) | 1998-11-10 | 2001-10-17 | Janssen Pharmaceutica N. V. | 2,4-disubstituted triazine derivatives |
-
1970
- 1970-05-13 JP JP45040664A patent/JPS4927592B1/ja active Pending
-
1971
- 1971-02-10 US US00114383A patent/US3740399A/en not_active Expired - Lifetime
- 1971-02-11 SE SE7101718A patent/SE394434B/en unknown
- 1971-02-16 NL NL717102022A patent/NL148797B/en unknown
- 1971-02-25 BE BE763425A patent/BE763425A/en unknown
- 1971-03-12 FR FR7108767A patent/FR2088532A1/fr not_active Withdrawn
- 1971-03-17 CH CH389571A patent/CH568304A5/xx not_active IP Right Cessation
- 1971-04-19 GB GB2195571A patent/GB1353545A/en not_active Expired
- 1971-05-03 DE DE19712121694 patent/DE2121694B2/en active Granted
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0864567A1 (en) * | 1995-11-27 | 1998-09-16 | Idemitsu Kosan Company Limited | Triazine derivatives |
EP0864567A4 (en) * | 1995-11-27 | 1998-12-30 | Idemitsu Kosan Co | Triazine derivatives |
US20060189614A1 (en) * | 1996-10-01 | 2006-08-24 | Janssen Paul A | Substituted diamino-1,3,5-triazine derivatives |
US6380194B1 (en) | 1996-10-01 | 2002-04-30 | Janssen Pharmaceutica N.V. | Substituted diamino-1,3,5-triazine derivatives |
US6858609B2 (en) | 1996-10-01 | 2005-02-22 | Janssen Pharmaceutica N.V. | Substituted diamino-1,3,5-triazine derivatives |
US6962916B2 (en) | 1996-10-01 | 2005-11-08 | Janssen Pharmaceutica N.V. | Substituted diamino-1,3,5-triazine derivatives |
US7449575B2 (en) | 1996-10-01 | 2008-11-11 | Janssen Pharmaceutica, Inc. | Substituted diamino-1,3,5-triazine derivatives |
US6150362A (en) * | 1997-12-12 | 2000-11-21 | Henkin; Jack | Triazine angiogenesis inhibitors |
WO2015007711A1 (en) * | 2013-07-16 | 2015-01-22 | Basf Se | Herbicidal azines |
AU2014292193B2 (en) * | 2013-07-16 | 2018-04-26 | Basf Se | Herbicidal azines |
EA031685B1 (en) * | 2013-07-16 | 2019-02-28 | Басф Се | Herbicidal azines |
US10479777B2 (en) | 2013-07-16 | 2019-11-19 | Basf Se | Herbicidal azines |
US10941122B2 (en) | 2014-04-11 | 2021-03-09 | Basf Se | Diaminotriazine derivatives as herbicides |
US10029992B2 (en) | 2014-04-23 | 2018-07-24 | Basf Se | Diaminotriazine compounds and their use as herbicides |
Also Published As
Publication number | Publication date |
---|---|
DE2121694B2 (en) | 1977-08-18 |
DE2121694A1 (en) | 1971-11-25 |
CH568304A5 (en) | 1975-10-31 |
NL148797B (en) | 1976-03-15 |
BE763425A (en) | 1971-07-16 |
GB1353545A (en) | 1974-05-22 |
NL7102022A (en) | 1971-11-16 |
SE394434B (en) | 1977-06-27 |
FR2088532A1 (en) | 1972-01-07 |
DE2121694C3 (en) | 1978-04-27 |
JPS4927592B1 (en) | 1974-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3272811A (en) | Dihydrothieno-[3, 4-d]-pyrimidines | |
US3740399A (en) | Diamino-s-triazines | |
DE3107583C2 (en) | ||
JPH07503021A (en) | Pyridine derivatives, their production methods and use as medicines | |
KR840001953B1 (en) | Process for preparing benzoguanamine derivatives | |
Overberger et al. | Preparation of Triazines by the Reaction of Biguanide and Esters1 | |
US2868803A (en) | New pyrazoles and method of preparing same | |
US2826580A (en) | Derivatives of y | |
US2756234A (en) | Anthrapyridones | |
US3028387A (en) | Dialkylaminoalkylaminopteridine derivatives | |
US3868383A (en) | Process for preparing 5-({60 -cyanobenzylidene) oxazolidine-2, 4-diones | |
SU474985A3 (en) | The method of obtaining 1-alkyl-4-phenyl-2 (1H) quinazolinone | |
US3536709A (en) | 2 - trichloromethyl - 4 - morpholino-6-(succinyloxy alkyl)amino - s - triazines and lower alkyl esters thereof | |
US3382246A (en) | Certain 3-(2'-pyridyl)-4(3h)-quinazolones | |
US3729468A (en) | Triazine derivatives and process for their preparation | |
US3040050A (en) | 1-(beta-phenyl-hydroxyethyl)-2-imino-1, 2-dihydropyridine and hydrochloride | |
US2309664A (en) | Method of preparing guanamines | |
US2980678A (en) | Pyrimidines | |
US3625979A (en) | Novel biologically active substituted-s-triazines | |
US3097205A (en) | Alkoxy or aryloxy | |
US2447440A (en) | Amino substituted aryl guanamines | |
US3223705A (en) | Salts of x,g-dlamino-i,z-dh-llydro-z-lower alkyl-i-aryl-s-triazenes | |
US3397200A (en) | Nitropyrrolylmethyleneaminouracils | |
DE2233862A1 (en) | PROCESS FOR THE PRODUCTION OF DIMETHYLMALEIC ACID ANHYDRIDE | |
US3290312A (en) | Triamino pteridine compounds |